Signalling by ubiquitination regulates virtually every cellular process in eukaryotes. Covalent attachment of ubiquitin to a substrate is catalysed by the E1, E2 and E3 three-enzyme cascade 1 , which links the carboxy terminus of ubiquitin to the ε-amino group of, in most cases, a lysine of the substrate via an isopeptide bond. Given the essential roles of ubiquitination in the regulation of the immune system, it is not surprising that the ubiquitination network is a common target for diverse infectious agents 2 . For example, many bacterial pathogens exploit ubiquitin signalling using virulence factors that function as E3 ligases, deubiquitinases 3 or as enzymes that directly attack ubiquitin 4 . The bacterial pathogen Legionella pneumophila utilizes approximately 300 effectors that modulate diverse host processes to create a permissive niche for its replication in phagocytes 5 . Here we demonstrate that members of the SidE effector family of L. pneumophila ubiquitinate multiple Rab small GTPases associated with the endoplasmic reticulum. Moreover, we show that these proteins are capable of catalysing ubiquitination without the need for the E1 and E2 enzymes. A putative mono-ADP-ribosyltransferase motif critical for the ubiquitination activity is also essential for the role of the SidE family in intracellular bacterial replication in a protozoan host. The E1/E2independent ubiquitination catalysed by these enzymes is energized by nicotinamide adenine dinucleotide, which activates ubiquitin by the formation of ADP-ribosylated ubiquitin. These results establish that ubiquitination can be catalysed by a single enzyme, the activity of which does not require ATP.
yeast toxicity 20, 21 , we created the SdeA E/A mutant, in which Glu860 and Glu862 were mutated to alanine. This mutant has completely lost its toxicity to yeast and was also defective in inhibiting the secretion of the secreted form of the embryonic alkaline phosphatase (SEAP) 22 by mammalian cells (Fig. 1b, c) . SidE, SdeB and SdeC also significantly inhibited SEAP secretion in a manner dependent upon the predicted mART motif (Extended Data Fig. 1a ). These results suggest that the putative mART motif is essential for the activity of the SidE family effectors.
A mutant missing the SidE family (∆sidE) shows attenuated virulence against the protozoan host Dictyostelium discoideum 15 (Fig. 2a ). Expression of wild-type SdeA but not the SdeA E/A mutant in a ∆sidE strain almost completely restored its ability to grow within the host ( Fig. 2a, b ). In D. discoideum, LCVs containing wild-type bacteria efficiently recruit endoplasmic reticulum (ER) markers such as the GFP-HDEL fusion to their surface, which is a hallmark of L. pneumophila infection 23, 24 . Similar to its defects in intracellular growth, the ∆sidE mutant no longer recruited GFP-HDEL to its vacuoles, even at 10 h post infection (Fig. 2c, d and Extended Data Fig. 1b, c) . Again, SdeA but not SdeA E/A complemented such defects ( Fig. 2c, d) . Thus, the putative mART motif is important for the function of the SidEs during bacterial infection.
Next we attempted to determine the potential ADP-ribosyltransferase activity of SdeA. Despite extensive efforts, we were unable to detect SdeA-mediated ADP-ribosylation of eukaryotic proteins (Extended Data Fig. 2a ), suggesting that this protein possesses a different biochemical activity. During L. pneumophila infection, members of the SidE family are transiently associated with the LCV 15 , an organelle resembling the ER 23 . Because Rab small GTPases are a common target of L. pneumophila effectors 25 , we examined whether SdeA attacks any of the ER-associated Rab proteins 26 by co-expressing 4×Flag-tagged Rab1, Rab6A, Rab30 or Rab33b with this effector in mammalian cells. A clear shift in molecular mass was observed for all four Rab proteins purified from cells co-transfected with SdeA but not SdeA E/A (Fig. 3a , left and middle panels). Such a molecular mass shift did not occur for the endosomal Rab5 or the cytoskeletal small GTPase Rac1 (Fig. 3a , right panel), indicating potential substrate specificity. Among the proteins potentially modified by SdeA, the modification of Rab33b was the most extensive, suggesting that this protein is a preferred substrate. The molecular mass shift in Rab33b also was observed when it was co-expressed with other members of the SidE family (Extended Data Fig. 2b ). To determine whether the potential post-translational modification occurs during bacterial infection, we infected mammalian cells expressing 4×Flag-Rab33b with L. pneumophila. Rab33b of higher molecular mass was detected in samples infected with the wild-type strain but not with strains lacking the Dot/Icm transporter or the SidE family (Fig. 3b ). The defect in Rab33b modification exhibited by the ∆sidE strain can be complemented by expressing SdeA but not SdeA E/A (Fig. 3b) . A similar SidE-dependent molecular mass LETTER RESEARCH shift also occurred to Rab1 during bacterial infection (Extended Data Fig. 2c ). Thus, SdeA induces a biochemical modification of multiple ER-associated Rabs, and at least Rab33b and Rab1 are substrates during bacterial infection.
We next determined the nature of the SdeA-induced post-translational modification by mass spectrometric analysis of 4×Flag-Rab33b purified from 293T cells expressing SdeA. Ubiquitin fragments were only detected in Rab33b of higher molecular mass (Fig. 3c, d and Extended Data Fig. 3a ). Similar results were obtained in Rab33b from cells infected with wild-type L. pneumophila (Fig. 3e, f) . These results suggest that Rab33b is involved in the formation of the LCV and that SdeA induces ubiquitination of Rab33b in a process that requires the putative mART motif. Indeed, overexpression of wild type Rab33b but not its dominant negative or dominant positive mutants 27 , inhibits the formation of vacuoles containing large number (>10) of bacteria ( Fig. 3g and Extended Data Fig. 3b ).
Ubiquitination requires enzymes E1, E2 and E3 which activates, conjugates and transfers the ubiquitin molecule to the substrate, Proteins identified by PSI-BLAST were manually aligned. Shown mART toxins are IotA from Clostridium perfringens 16 , the C3 exoenzyme from Clostridium botulinum 17 and ExoS from Pseudomonas aeruginosa 18 . Residues important for the mART motif were highlighted in red. b, c, The mART is essential for yeast toxicity and for secretion inhibition by SdeA. Yeast cells were spotted on the indicated medium for 3 days before image acquisition. The secretion of SEAP was examined in 293T cells transfected to express SEAP and GFP-tagged testing proteins; the strong SEAP inhibitor AnkX 22 was used as a control. Error bars represent s.e.m. (n = 3). The expression of the proteins (the lower panel in b for yeast and the right panel in c for mammalian cells) was probed with indicated antibodies. The PGK (3-phosphoglyceric phosphokinase) and tubulin were probed as a loading control, respectively. SdeA E/A , SdeA with Glu860 and Glu862 mutated to Ala. IB, immunoblotting. The yeast toxicity results in b and protein levels in b and c are from one representative of three independent experiments. The SEAP results in c are one representative done in triplicate from three independent experiments. b, c, Uncropped blots are shown in Supplementary Fig. 1 . Figure 2 | The predicted mART motif is essential for the role of SdeA in intracellular bacterial growth. a, The indicated bacterial strains were used to infect D. discoideum and the bacterial yields were monitored at 24-h intervals. Note that SdeA but not the SdeA E/A mutant restored the defect exhibited by the ∆sidE strain. CFU, colony-forming units. LETTER RESEARCH respectively 1 . We thus used in vitro reactions to determine whether SdeA directly participates in the ubiquitination of Rab33b. In a series of reactions each containing E1 and one of several E2 enzymes, no ubiquitination of Rab33b was detected (Extended Data Fig. 3c ). We thus tested the hypothesis that an unknown E2 is required for the activity of SdeA by adding cell lysates to the reactions, which led to ubiquitination of Rab33b in an mART-dependent manner ( Fig. 4a ). Unexpectedly, ubiquitination still occurred in reactions receiving heat-treated cell lysates (Fig. 4a , lane 3), suggesting that both E1 and the putative SdeAspecific E2 are heat-stable or that SdeA is able to catalyse ubiquitination by itself but only in the presence of heat-stable molecule(s) from cells. To distinguish between these two possibilities, we added E. coli lysates to the reaction. Notably, ubiquitination of Rab33b did occur (Fig. 4a, lane 4) . These results demonstrate that SdeA catalyses E1/E2-independent ubiquitination in a process that requires one or more heat-stable molecules present in cells.
Classic ubiquitination requires the conserved E1 that activates ubiquitin in a process powered by hydrolysis of ATP, which binds the enzyme in a Mg 2+ -dependent manner 1 . We thus determined the requirement of these molecules in SdeA-mediated ubiquitination. Because of the importance of the mART motif in the cleavage of NAD by canonical ADP-ribosyltransferases 19 , we included this compound in our reactions. In reactions containing NAD, Mg 2+ and ATP, ubiquitination of Rab33b occurred (Fig. 4b, lane 2 ). Yet, when NAD was withdrawn, no ubiquitination was detected (Fig. 4b, lane 3) . In line with this observation, ubiquitination occurred in reactions containing NAD but not ATP or Mg 2+ (Fig. 4b , lanes 4 and 5). Heattreated NAD is active, which is consistent with the fact that boiled cell lysates allowed SdeA to function (Fig. 4b, lane 8) . Exogenous NAD is sufficient for the activity of SdeA that had been dialysed against a buffer containing EDTA (Extended Data Fig. 4a ), suggesting that this compound is the only co-factor required for the activity. SdeA E/A is unable to catalyse the modification even in the presence of NAD (Fig. 4b, lane 9 ). Under this condition, both Rab1 and Rab6A were ubiquitinated by SdeA (Extended Data Fig. 4b ). Similarly, SidE, SdeB and SdeC ubiquitinated Rab33b (Extended Data Fig. 4c ).
Consistently, SdeA does not detectably ADP-ribosylate Rab33b or Rab1 (Extended Data Fig. 5a ).
Since ubiquitin ligases often self-modify 1 , we incubated SdeA with glutathione S-transferase (GST)-tagged ubiquitin to probe such self-ubiquitination. Proteins of higher molecular mass were detected in reactions containing SdeA but not SdeA E/A , again in a NAD-dependent manner (Fig. 4c ). The central domain of SdeA remains toxic to yeast 20 , suggesting that it is still biochemically active. Indeed, SdeA 178-1000 robustly ubiquitinates itself and Rab33b in a manner that requires both NAD and the mART motif ( Fig. 4d ). These results demonstrate that the N-terminal deubiquitinase (DUB) domain 28 of SdeA does not interfere with its ubiquitin conjugation activity. Indeed, the SdeA C118A mutant defective in the DUB activity 28 catalyses ubiquitination indistinguishably to that of the wild-type protein (Extended Data Fig. 5b , c).
Mass spectrometric and mutational analyses revealed that Arg42 of ubiquitin is important for SdeA-mediated, but not for canonical ubiquitination catalysed by the E1-E2-E3 cascade (Extended Data Fig. 6a, b ). Consistent with these results, SdeA ubiquitinates Rab33b with all lysine variants of ubiquitin, as well as the ubiquitin derivative containing an alanine substitution in the last two glycine residues or with six histidine residues attached to its carboxy terminus (Extended Data Fig. 6c-e ). Further, ubiquitination catalysed by SdeA is insensitive to the cysteine alkylation agent maleimide, suggesting that a cysteine conjugation of ubiquitin does not form during the reaction (Extended Data Fig. 7 ). Finally, ubiquitination by SdeA affected the GTP loading and hydrolysis activity of Rab33b but did not detectably affect its stability ( Fig. 3a and Extended Data Fig. 8 ). The nucleotide binding status of Rab33b did not affect its suitability as the substrate of SdeA (Extended Data Fig. 8e ).
We detected AMP, nicotinamide, ubiquitin and NAD in SdeAcatalysed reactions (Extended Data Fig. 9 ). The release of AMP suggests the formation of an ubiquitin-AMP adduct during the reaction. Yet, the ubiquitin-AMP adduct could not be detected by 32 P-α-NAD or by TCA precipitation followed by high-performance liquid chromatography-mass spectrometry (HPLC-MS) (Extended Data Fig. 10a ). The release of nicotinamide and the requirement of Arg42 of ubiquitin Supplementary Fig. 1 . 
LETTER RESEARCH
implied ADP-ribosylation of this side chain as a possible step before ubiquitin conjugation, which is consistent with the requirement of the R-S-ExE motif found in members of the SidE protein family. Thus, we probed the reaction intermediate by obtaining SdeA 519-1100 , a fragment that retained the ability to modify Rab33b but had lost the self-ubiquitination activity (Extended Data Fig. 10b , c). Incubation of SdeA 519-1100 with NAD and ubiquitin led to the release of nicotinamide (Extended Data Fig. 10d ), suggesting the formation of ADP-ribosylated ubiquitin. Furthermore, inclusion of 32 P-α-NAD in the reaction produced 32 P-labelled ubiquitin in an Arg42-dependent manner and the ADP-ribosyl moiety linked to Arg42 of ubiquitin can be detected by mass spectrometric analysis (Extended Data Fig. 10e-g) . Thus, ADP-ribosylated ubiquitin is the reaction intermediate. The production of AMP in reactions with full-length SdeA could be a subsequent step in the attack of an acceptor nucleophile (from the Rab proteins or SdeA itself in the self-conjugation reaction) on the ADP-ribosylated ubiquitin leading to the modification of the target protein.
In a canonical ubiquitination reaction, ubiquitin activated by E1 is delivered to E2 to form the E2~Ub thioester. For the E3 ligases of the RING family, ubiquitin is directly transferred from the E2 to a substrate facilitated by the ligases, whereas members of the HECT and RBR E3 families transfer ubiquitin to a catalytic cysteine in the E3 before delivering it to the substrate 1 . Clearly, SdeA defines an all-in-one ubiquitin conjugation enzyme that directly activates ubiquitin; the fact that SdeA 519-1100 defective in auto-ubiquitination can still modify Rab33b suggests that the activated ubiquitin is directly transferred to the substrate.
The discovery that ubiquitin can be modified by ADP-ribosylation expands the post-translational modification on this prevalent signalling molecule, which has been shown to be modified by acetylation and phosphorylation 29 . Whether ADPR~Ub itself is directly used to modify proteins is unknown, but it is clear that such modifications can potentially lead to significant expansion of the ubiquitin code and its functions in cellular processes and disease development 29 . The mART motif is present in a family of mammalian proteins, some of which are unable to catalyse ADP-ribosylation 30 . In light of the mARTdependent ubiquitination activity of SdeA, it will be interesting to determine whether any of these mART-containing proteins is capable of catalysing ubiquitination, and if so, whether the reaction requires E1 and E2. The identification of eukaryotic mART proteins with such a capability will surely expand the spectrum of cellular processes regulated by ubiquitination. 

METHODS
Bacterial, yeast strains and plasmid construction. L. pneumophila strains used in this study were derivatives of the Philadelphia 1 strain Lp02 (ref. 31 ) and were grown and maintained on CYE medium or in AYE broth as previously described 31 . When necessary antibiotics were included as described 31 . The ∆sidE strain was made by step-wise deletion of the 4 members using an established method 6 . For complementation experiments, the genes were inserted into pZL507 (ref. 32 ). All infections were performed with bacterial cultures grown to the post-exponential phase as judged by optical density of the cultures (OD 600 = 3.3-3.8) as well as increase of bacterial motility. For expression in mammalian cells, genes were cloned into pEGFPC1 (Clontech) or a 4×Flag vector 32 . The integrity of all constructs was verified by sequencing analysis. Cell culture, infection, transfection and co-immunoprecipitation. HEK293 or 293T cells (ATCC) were cultured in Dulbecco's modified minimum Eagle's medium (DMEM) supplemented with 10% FBS. Cells grown to about 80% confluence were transfected with Lipofectamine 3000 (Life Technology) following manufacturer's instructions. U937 cells (ATCC) were differentiated into macrophages as described 33 . D. discoideum strains AX4 and AX4-HDEL-GFP were cultured in HL-5 medium as described earlier 34 . Strains of L. pneumophila used for infection were grown in AYE to post-exponential phase judged by optical density (OD 600 = 3.2-4.0) and by increase in motility. 2 × 10 5 D. discoideum cells seeded in 24-well plates were infected with an MOI of 0.05 for growth experiments and of 5 for immunostaining. In all cases, one hour after adding bacteria to cultured cells, infections were synchronized by washing the infected cells three times with warm PBS buffer. Total bacterial counts at indicated time points were determined by plating serially diluted saponin lysates onto bacterial media. To determine the development of the LCV in COS1 cells (ATCC) expressing Rab33b and its mutants, cells transfected for 14 h were infected with wild-type L. pneumophila and samples were fixed 14 h after bacterial uptake. Intracellular and extracellular bacteria were differentially stained with a Legionella-specific antibody and secondary antibodies conjugated to different fluorescence dyes. The category of LCVs was scored visually under a fluorescence microscope. All cell lines used were directly purchased from ATCC and were free of mycoplasma contamination by monthly testing using the PlasmoTest Kit (Invivogen).
For infections to determine the modification of Rab33b, HEK293 cells were transfected to express 4×Flag-Rab33b and FCγRII for 24 h with Lipofectamine 3000 (Life Technology). Bacteria of relevant L. pneumophila strains were opsonized with rabbit anti-Legionella antibodies 32 at 1:500 for 30 min before infecting the cells at an MOI of 10 for 2 h. Lysates prepared from infected cells with RIPA buffer (Thermo Fisher Scientific) were subjected to immunoprecipitation with Flag beads (Sigma-Aldrich).
To determine protein translocation by L. pneumophila, cells infected with the indicated bacterial strains were lysed with 0.2% saponin, which lyses membranes of mammalian cells but not of bacterial cells. The lysates were directly probed for SdeA with a specific antibody.
The secretion of SEAP was measured 24 h after cells were transfected with plasmids carrying the testing genes and pSEAP 22, 35 . The alkaline phosphatase activity was determined with Tropix phosphalight System kit (Applied Biosystems) per the manufacturer's instructions. Yeast toxicity assays. All yeast strains used were derived from W303 (ref. 36); yeast was grown at 30 °C in YPD medium or in appropriate amino acid dropout synthetic media with glucose or galactose at a final concentration of 2% as the sole carbon source. Yeast transformation was performed according to a standard procedure 37 . Inducible protein toxicity was assessed by the galactose-inducible promoter on pSB157 (ref. 38) . SdeA or its mutant was inserted into pSB157 and the resulting plasmids were linearized before transforming into yeast strain W303 (ref. 36) . Yeast strains grown in liquid selective medium containing glucose were serially diluted fivefold, and 10 μl of each dilution was spotted onto selective plates containing glucose or galactose. Plates were incubated at 30 °C for 3 days before the images were acquired. Protein purification. To purify Flag-Rab33b from mammalian cells, 293T cells transfected with the indicated plasmids for 24 h were lysed with RIPA buffer. Flagantibody-coated beads were added to cleared lysates and obtained by centrifugation at 12,000g for 10 min. The mixtures were incubated at 4 °C with agitation for 4 h. Unbound proteins were removed by washing the beads three times with RIPA buffer and the Flag-tagged proteins were eluted with 450 μg ml −1 3 × Flag peptide solution. To purify modified Rab33b from infected cells, HEK293 cells transfected to express 4×Flag-Rab33b and FCγRII were infected with wild type L. pneumophila for 2 h. The samples were lysed with RIPA buffer. Flag-Rab33b from the infection samples were purified followed the same protocol used for transfection samples.
Unless otherwise specified, the E. coli strain BL21(DE3) was used as the host for expression and purification of recombinant proteins. Rab1 was purified as GST-tagged protein, while all other proteins were purified as His 6 -tagged proteins. pQE30-4×Flag-Rab33b was sub-cloned from the mammalian expression vector p4×Flag-Rab33b to produce His 6 -4×Flag-Rab33b. For protein production, 30 ml of overnight culture of the E. coli strain harbouring the appropriate plasmid was transferred to 750 ml LB medium (ampicillin 100 μg ml −1 ) and grown until OD 600 of 0.6-0.8 was reached. After adding IPTG (isopropyl thio-d-galactopyranoside) to a final concentration of 0.2 mM, the cultures were further incubated in a shaker at 18 °C for 16~18 h. Bacterial cells were harvested by spinning at 12,000g and lysed by sonication in the presence of protease inhibitors. The soluble fractions were collected by centrifugation at 12,000g twice at 4 °C. His-tagged proteins were purified with Ni 2+ -NTA beads (Qiagen), and eluted with PBS containing 300 mM imidazole; GST-Rab1 were purified with Glutathione Sepharose 4 Fast Flow beads (GE healthcare), and proteins bound to beads were eluted with 25 mM reduced glutathione in 20 mM Tris-HCl, pH 8.0, 100 mM NaCl. Purified proteins were dialysed in a buffer containing 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5% glycerol, 1 mM DTT. To determine the potential involvement of the ions and other co-factors in the activity of SdeA, the protein was dialysed against the same buffer containing 10 mM EDTA for 14 h at 4 °C. Protein concentrations were determined by the Bradford assay. For proteins used in in vitro biochemical assays, extensive dialysis was performed with at least two buffer changes. The purity of proteins was larger than 95% as assessed by Coomassie brilliant blue staining. In vitro ubiquitination assays. E1, E2 and ubiquitin were obtained from Boston Biochem and were used at 100 nM for each 50-μl reaction. Ubiquitination assays were performed at 37 °C for 2 h in a reaction buffer containing 50 mM Tris-HCl (pH 7.5), 0.4 mM β-nicotinamide adenine dinucleotide (β-NAD) (Sigma-Aldrich) and 1 mM DTT. Each 50-μl reaction contains 10 μg ubiquitin, 5 μg SdeA, SdeB, SdeC, SidE or their mutant proteins and 5 μg substrates. When necessary, ATP and Mg 2+ were added to a final concentration of 2 mM and 5 mM, respectively. When needed, 50 μg of mammalian or E. coli lysates were added. Heat treatment of cell lysates or NAD was performed at 100 °C for 5 min. When necessary maleimide (MEM) was added to in vitro reactions at a final concentration of 50 μM. Antibodies, immunostaining and immumobloting. Antibodies against Legionella and GFP were described elsewhere 32 . Antibodies specific for SdeA were prepared by injecting rabbits with purified protein (Pocono Rabbit Farm and Laboratory, Canadensis, PA) following a standard procedure used by the service provider. When necessary, antibodies were affinity-purified against the same proteins covalently coupled to an Affigel matrix (Bio-Rad) using standard protocols 39 . Cell fixation, permeabilization and immunostaining were performed as described 40 . For immunostaining, anti-Legionella antisera were used at 1:10,000 (ref. 32) . Intracellular bacteria were distinguished from extracellular bacteria by differential immunostaining with secondary antibodies of distinct fluorescence dyes. Processed samples were inspected and scored using an Olympus IX-81 fluorescence microscope.
For immunoblotting, samples resolved by SDS-PAGE were transferred onto nitrocellulose membranes. After blocking with 5% milk, membranes were incubated with the appropriate primary antibody: anti-GFP (Sigma, cat. no. G7781), 1:10,000; anti-GST (Sigma, cat. no. G6539), 1:10,000; anti-Flag (Sigma, F1804), 1:2,000; anti-ICDH, 1:10,000; anti-PGK (Life Technology, cat. no. 459250), 1:3,000; anti-SdeA, 1:10,000; anti-SidC 6 , 1:10,000; anti-Ub (Santa cruz, cat. no. sc-8017), 1:1,000; anti-His (Sigma, cat. no. H1029), 1:10,000. Tubulin (DSHB, E7), 1:10,000. Membranes were incubated with an appropriate IRDye infrared secondary antibody (Li-Cor's Biosciences Lincoln, Nebraska, USA) and the signals were obtained by using the Odyssey infrared imaging system. GTP loading assay. For 35 SγGTP incorporation assays, 20 μg of 4×Flag-Rab33b was loaded with unlabelled GDP (5 mM) before ubiquitination as described 22 . GDP loaded 4×Flag-Rab33b was used for ubiquitination assays in the presence of either SdeA (10 μg) or SdeA E/A (10 μg) for 2 h at 37 °C. 20% of the samples were withdrawn to test for the extent of ubiquitination of 4×Flag-Rab33b by SDS-PAGE and Coomassie staining. Ubiquitinated or non-ubiquitinated 4×Flag-Rab33b was incubated in 50 μl nucleotide exchange buffer containing 25 mM Tris-HCl (pH 7.5), 50 mM NaCl, 5 mM MgCl 2 , and 0.1 mM EDTA with 5 μCi 35 SγGTP (Perkin-Elmer). GTP-loading reactions were performed at 22 °C. Aliquots of reactions were withdrawn at indicated time points, passed through nitrocellulose membrane filters (Hawp02500; Millipore) and placed onto a vacuum platform attached to a waste liquid container. Membranes were washed three times using the exchange buffer to remove the free nucleotides, and were then transferred into scintillation vials containing 8 ml scintillation fluid (Beckman). Incorporated 35 SγGTP was detected by a scintillation counter at 1 min per count. GTPase assay. 20 μg of 4×Flag-Rab33b was used for ubiquitination assays in the presence of either SdeA (10 μg) or SdeA E/A (10 μg) for 2 h before 5 μCi of 32 PγGTP (Perkin-Elmer) was added to the reactions. Nucleotide loading was performed at 22 °C for 30 min. Aliquots of the reactions were withdrawn and passed through LETTER RESEARCH membranes as described in the GTP loading assay. The reading of these aliquots served as starting points for different reactions. Samples withdrawn at later time points were measured for 32 PγGTP and retained by 4×Flag-Rab33b-bound with a scintillation counter. The GTP hydrolysis index was calculated by dividing the readings obtained in later time points by the values of the starting point. ADP-ribosylation assay. 5 μg of SdeA or SdeA E/A was incubated with 5 μg of GST-Rab1, 4×Flag-Rab33b or 100 μg of 293T cell lysate in the presence of 10 mM Tris-HCl (pH 7.5), 20 mM NaCl. 5 μCi of 32 P-α-NAD (Perkin-Elmer) was added to each reaction. ADP-ribosylation assays were performed at 22 °C for 1 h and were stopped by adding 5 × SDS loading buffer. A reaction containing ExoS 78-453 (200 ng), FAS (factor activating ExoS) (2 μg), Rab5 (5 μg) or 293T cell lysates (100 μg) was used as positive control. The incorporation of 32 P-α-ADPR into proteins was detected by autoradiography. Detection of reaction intermediates by 32 P-labelled ATP and NAD. To detect the ubiquitin intermediate, 5 μg of SdeA or SdeA 519-1100 was incubated with 10-μg GST-ubiquitin, GST-ubiquitin R42A or GST in the presence of 32 P-α-NAD (5 μCi) in a reaction buffer containing 50 mM Tris-HCl (pH 7.5). The reaction was performed at 37 °C for 6 h and stopped by adding 5 × SDS loading buffer. A reaction containing the E1 activating enzyme (1 μg), GST-ubiquitin or GST (10 μg), 32 P-α-ATP (5 μCi) in the presence of 50 mM Tris-HCl (pH 7.5) and 2 mM MgCl 2 was used as a positive control. The 32 P-labelled intermediates were detected by autoradiography. Detection of reaction intermediates. To detect AMP generated in reactions catalysed by SdeA, reactions were set up with 50 μg SdeA 178-1000 , 10 mM NAD and 450 μg ubiquitin in reaction buffer (50 mM Tris pH 7.6, 50 mM NaCl, 1 mM DTT) and allowed to react for 2 h at 22 °C. To detect all reaction intermediates, a reaction was set up with 100 μg SdeA 178-1000 , 1 mM NAD and 100 μg ubiquitin in reaction buffer (50 mM Tris pH 7.6, 50 mM NaCl, 1 mM DTT) and allowed to react for 16 h at 22 °C. The reaction was then separated on an Agilent C8 column using a Waters 600 HPLC system with a linear gradient of 0-5% (v/v) acetonitrile in water over 25 min at 1 ml per minute. The intermediates were detected with a Waters 2487 dual wavelength detection system with wavelengths set to 260 nm and 280 nm. The mixture was then directly analysed with a Waters micromass ZQ spectrometer in negative electrospray ionization mode. The detection range was set from 100-700 (m/z) with a scans at 1 s intervals. Standard samples of AMP, ADP, NMN, and nicotinamide were set up in parallel and analysed following the same method to determine the elution profile of each possible intermediate.
For experiments using SdeA 519-1100 defective in autoubiquitination, 50 μg SdeA 519-1100 was incubated with 15 μg ubiquitin and 1 mM NAD in reaction buffer (50 mM Tris pH 7.6, 50 mM NaCl, 1 mM DTT) at 22 °C for 18 h. The reaction was then applied directly to an Agilent C8 column on a Waters 600 HPLC system. The products of the reaction were separated with a linear gradient of 0-5% (v/v) acetonitrile in water with a flow rate of 1 ml per min over 25 min. The products were detected with a Waters 2487 dual wavelength detection system set to 260 nm and 280 nm. Controls used were 1 mM solutions containing only NAD, nicotinamide or AMP.
Samples for mass spectrometric analysis were obtained by using His 6 -ubiquitin in reactions containing SdeA 519-1100 and NAD for 2 h, SdeA 519-1100 and other components were removed by Ni 2+ beads chromatography. Eluted proteins were separated in SDS-PAGE and the band corresponding ubiquitin was excised and digested with trypsin. Resulting peptides were analysed in a NanoAcquity nano-HPLC system (Waters) by loading peptides into a trap column (5 cm × 150 μm i.d. column packed in-lab with 5 μm Jupiter C18 stationary phase) and separated in a 40 cm × 75 μm i.d. column packed in-lab with 3 μm Jupiter C18 stationary phase. The elution was carried out at 300 nl per min with the following gradient: 0-8% B solvent in 2 min, 8-20% B in 18 min, 12-30% B 55 min, 30-45% B in 22 and 97-100% B in 3 min, before holding for 10 min at 100% B. Eluting peptides were introduced to the mass spectrometer (Q-Exactive HF, Thermo Fisher Scientific) using electrospray ionization and mass spectra were collected from 400-2,000 m/z with 100,000 resolution at m/z 400. HCD tandem-mass spectra were collected by data-dependent acquisition of the 12 most intense ions using normalized collision energy of 30%. A dynamic exclusion time of 45 s was used to discriminate against previously analysed ions. Spectra were analysed manually by de novo sequencing. Data quantitation and statistical analyses. Student's t-test (two-sided) was used to compare the mean levels between two groups each with at least three independent samples. No statistical methods were used to predetermine sample size. 
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Extended Data Figure 8 | SdeA-mediated ubiquitination affects the activity but not stability of Rab33b and SdeA ubiquitinates Rab33b independently of its nucleotide binding status. a, Evaluation of the ubiquitinated Rab33b. 4×Flag-Rab33b was loaded with unlabelled GDP (5 mM) before ubiquitination reaction. GDP-loaded Rab33b was subjected to ubiquitination by SdeA or SdeA E/A for 2 h at 37 °C; 20% of the samples were withdrawn to determine the extent of ubiquitination by Coomassie staining. b, Ubiquitination affected the GTP loading activity of Rab33b. Ubiquitinated or non-ubiquitinated 4×Flag-Rab33b was incubated in 50 μl nucleotide exchange buffer containing 5 μCi 35 SγGTP at 22 °C. Aliquots of reactions were withdrawn at indicated time points and passed through nitrocellulose membrane filters. Membranes were washed for three times using exchange buffer before being transferred into scintillation vials containing scintillation fluid to detect incorporated 35 SγGTP with a scintillation counter. c, Ubiquitination affected the GTPase activity of Rab33b. Samples withdrawn from Ub~Rab33b or Rab33b loaded with 32 PγGTP were measured for the associated radioactivity to set as the starting point. Equal volumes of samples were withdrawn at the indicated time points to monitor intrinsic GTP hydrolysis. The GTP hydrolysis index was calculated by dividing the readings obtained in later time points by the values of the starting point.
Similar results (a-c) were obtained in three independent experiments and the data shown were from one representative experiment. d, SdeAmediated ubiquitination does not lead to degradation of Rab33b. GFP fusion of SdeA or SdeA E/A was co-transfected with Rab33b for 14 h. The proteasome inhibitor MG132 (10 μM) was added to one of the SdeA samples. The levels of Rab33b were detected by immunoblotting following immunoprecipitation with the Flag-specific antibody. Note that the addition of MG132 does not affect the level of modified Rab33b in samples co-transfected with SdeA. Similar results were obtained from two independent experiments. e, The nucleotide binding status of Rab33b does not affect its suitability as substrate in SdeA-mediated ubiquitination. Equal amounts of Rab33b, its dominant negative mutant Rab33b(T47N), or the dominant positive mutant Rab33b(Q92L) was incubated with SdeA. Samples withdrawn at the indicated time points were detected for ubiquitination by Coomassie staining (upper panel); 293T cells transfected to express these mutants were infected the indicated L. pneumophila strains and ubiquitinated Rab33b or its mutants were probed by molecular mass shift in Rab33b obtained by immunoprecipitation (lower panel). Data in this panel are one representative of two independent experiments with similar results. a, d, e, Uncropped blots and gel images are shown in Supplementary Fig. 1. 
